Vermillion & White Wealth Management Group, LLC Lexicon Pharmaceuticals, Inc. Transaction History
Vermillion & White Wealth Management Group, LLC
- $135 Billion
- Q3 2024
A detailed history of Vermillion & White Wealth Management Group, LLC transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vermillion & White Wealth Management Group, LLC holds 13,415 shares of LXRX stock, worth $9,122. This represents 0.02% of its overall portfolio holdings.
Number of Shares
13,415
Previous 12,415
8.05%
Holding current value
$9,122
Previous $20.9 Million
0.98%
% of portfolio
0.02%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LXRX
# of Institutions
141Shares Held
238MCall Options Held
459KPut Options Held
133K-
Artal Group S.A. Luxembourg, N4136MShares$92.6 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$26.5 Million3.05% of portfolio
-
Orbimed Advisors LLC San Diego, CA11MShares$7.5 Million0.41% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$6.73 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.09MShares$5.5 Million0.0% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $128M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...